Latest Articles
Society of Radiologists in Ultrasound Consensus on Routine Pelvic US for Endometriosis - RSNA Publications Online
Society of Radiologists in Ultrasound Consensus on Routine Pelvic US for Endometriosis RSNA Publications Online
Published: April 9, 2024, 7 a.m.
Endometriosis: What Every Woman Should Know - Lee Health
Endometriosis: What Every Woman Should Know Lee Health
Published: April 9, 2024, 7 a.m.
Patient Takes Charge of Endometriosis Diagnosis - UT Physicians
Patient Takes Charge of Endometriosis Diagnosis UT Physicians
Published: April 9, 2024, 7 a.m.
SRU releases consensus statement on endometriosis detection - AuntMinnie
SRU releases consensus statement on endometriosis detection AuntMinnie
Published: April 9, 2024, 7 a.m.
Padma Lakshmi Shares Her Endometriosis Story at Boston Leadership Conference - Endometriosis Foundation of America - The Blossom
Padma Lakshmi Shares Her Endometriosis Story at Boston Leadership Conference Endometriosis Foundation of America - The Blossom
Published: April 9, 2024, 7 a.m.
8 Questions to Ask About Your Endometriosis Treatment - Health Central
8 Questions to Ask About Your Endometriosis Treatment Health Central
Published: April 9, 2024, 7 a.m.
New Consensus Statement Aims to Improve Endometriosis Evaluation - Imaging Technology News
New Consensus Statement Aims to Improve Endometriosis Evaluation Imaging Technology News
Published: April 9, 2024, 7 a.m.
New Consensus Statement Aims to Improve Endometriosis Evaluation - RSNA
New Consensus Statement Aims to Improve Endometriosis Evaluation RSNA
Published: April 9, 2024, 7 a.m.
Umbilical cord mesenchymal stem cell-derived exosomes inhibits fibrosis in human endometrial stromal cells via miR-140-3p/FOXP1/Smad axis - Nature.com
Umbilical cord mesenchymal stem cell-derived exosomes inhibits fibrosis in human endometrial stromal cells via miR-140-3p/FOXP1/Smad axis Nature.com
Published: April 9, 2024, 7 a.m.
AstraZeneca, Daiichi Sankyo's Enhertu wins historic HER2 tumor-agnostic FDA nod - FiercePharma
AstraZeneca, Daiichi Sankyo's Enhertu wins historic HER2 tumor-agnostic FDA nod FiercePharma
Published: April 8, 2024, 7 a.m.
Link copied to clipboard!